Inclusion criteria were assessed after a 7-day interruption of PPI therapy using oesophago-gastro-duodenoscopy (EGD), 24-hour pH impedance monitoring, and high-resolution manometry (HRM). Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback